Patents by Inventor Traci Roberts

Traci Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies directed against IL-17
    Patent number: 9328166
    Abstract: The invention relates to an isolated interleukin-17 (IL-17)-binding agent which comprises an immunoglobulin heavy chain polypeptide comprising SEQ ID NO: 1, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 78, or SEQ ID NO: 79, and an immunoglobulin light chain polypeptide comprising SEQ ID NO: 23, except that one or more specific of residues of SEQ ID NO: 1 and SEQ ID NO: 23 are replaced with a different residue. The invention also provides vectors, compositions, and methods of using the IL-17-binding agent to treat an IL-17-mediated disease.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: May 3, 2016
    Assignee: AnaptysBio, Inc.
    Inventors: Robert Horlick, David King, Peter Bowers, Jennifer Dalton, Betty Wu, Traci Roberts, Xue Zhang, Laurence Altobell, III
  • ANTIBODIES DIRECTED AGAINST IL-17
    Publication number: 20130202591
    Abstract: The disclosure relates to an isolated IL-17-binding agent which comprises an immunoglobulin heavy chain polypeptide comprising SEQ ID NO: 1 and optionally an immunoglobulin light chain polypeptide comprising SEQ ID NO: 23, except that one or more specific of residues of SEQ ID NO: 1 and SEQ ID NO: 23 are replaced with a different residue. The disclosure also provides vectors, compositions, and methods of using the IL-17-binding agent to treat an IL-17-mediated disease.
    Type: Application
    Filed: August 2, 2011
    Publication date: August 8, 2013
    Applicant: ANAPTYSBIO, INC.
    Inventors: Robert Horlick, David King, Peter Bowers, Jennifer Dalton, Betty Wu, Traci Roberts, Xue Zhang, Laurence Altobell, III